Latest article
Novo Nordisk presents trial outcomes of Xultophy for kind 2 diabetes
Novo Nordisk said Monday that its type 2 diabetes treatment Xultophy showed superior efficacy in reducing hemoglobin A1c (HbA1c) levels, weight change and lower...
Out-Licencing Program Helps Diabetes Therapy Development Labmate On-line
The Danish spin-out PanCryos...
Coronavirus: Kiwi COVID misinformation group Voices for Freedom removes web page selling ‘important oils’
Questioning science
Newshub asked Voices for Freedom what medical or scientific qualifications their organizers had. Bland said the group's material...